
Statement by the President of the Chamber of Deputies occurred during a hearing with Minister Paulo Teixeira, parliamentarians, and representatives of associations on the regulation of PL 399/2015

In theory, patients should have access to products for the treatment of a limited number of conditions, but NHS prescriptions remain very low

The Caribbean island's Parliament has approved legislative amendments allowing limited possession and home cultivation for individuals over 21 years old

An analysis of the medicinal use of cannabis in managing the condition

Proposed recriminalization of plant derivatives could cost the sector dearly, experts warn

Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol by the SUS

Unraveling the mysteries of an ancient deity and its connections to cannabis

STJ decision reinforces federal competence for actions involving unregistered drugs at the regulatory agency

STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency

The change represents a remarkable turnaround for the country, which was once famous as a major center for marijuana trafficking in Europe

Process could determine whether the genetics will be classified as a genetically modified organism or treated as a conventional plant in Brazil

Produced in Santa Catarina, the drink has a cannabis aroma but does not have psychoactive properties

The Ministry of Agriculture is finalizing a technical note related to the bill currently in the Senate

Entrepreneur Fabrício Penafiel considers the inclusion of practical experience of producers in the proposal, with a deadline set for September 30th, a historic opportunity.

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

New RDC No. 1,011 expands regulatory details on Cannabis derivatives, medicinal products, and pharmaceutical inputs

Anvisa's update "mirrors" the rules for controlling cannabis products directly in the list of controlled substances and defines classification for industrial inputs

With applications ranging from the pharmaceutical industry to construction, the sector is being structured with machinery, research, and investments, and is expected to grow even before the definitive regulation of cultivation in Brazil; the consultant discussed the topic during an interview at Andav 2025

After years of deadlock, decree should allow Colombian patients access to cannabis flower with a medical prescription

Company demands urgent measures in face of new missed deadlines by the government and Anvisa and proposes experimental environment under judicial supervision